Method for determining four potential genotoxic impurities in perampanel bulk drug
Through high-performance liquid chromatography determination method, the detection problems of four potential genotoxic impurities in perampanai raw materials were solved, and fast and simple detection and quality control were achieved, ensuring the accuracy and stability of the detection.
Patent Information
- Application Number
- CN202310507472.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-08
- Publication Date
- 2024-11-08
AI Technical Summary
The existing methods cannot effectively determine the four potential genotoxic impurities in perampanai raw materials, especially the determination of impurities 2 and 4 cannot be met under chromatographic conditions, resulting in the inability to effectively control their genotoxicity.
Using high performance liquid chromatography, a Welch Ultimate PFP column was used, with acetonitrile as mobile phase, 10 mmol of ammonium dihydrogen phosphate as buffer, gradient elution and detection wavelength were set to 250 nm, and acetonitrile was passed through the diluent: water = 70: 30(v:v) Prepare test and reference solution to ensure the detection and quality control of impurities 2, 4, 6, and 8.
It has achieved rapid and simple detection of four potential genotoxic impurities, with good linear relationship between peak area and concentration, high recovery rate, excellent repeatability and stability, suitable for quality control, and the lower detection limit and quantitative limit meet the requirements.
Smart Images

Figure CN118914379A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedicine, and in particular relates to a method for determining four potential genotoxic impurities in a perampanel raw material drug. Background Art
[0002] Perampanel (PER) is a third-generation antiepileptic drug (AEDs) developed by Eisai Co., Ltd. of Japan. It is also the first highly selective non-competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) type glutamate receptor antagonist for the treatment of epilepsy.
[0003] PER is a compound containing a nitrogen heterocyclic structure. The product generated under oxidative conditions has a genotoxic warning structure. Figure 1 ) It can be seen that the starting material 1 and the two intermediates 3 and 5 of PER (7) are all nitrogen-containing heterocyclic rings, and they may produce aromatic nitrogen oxides during storage or reaction. Therefore, these four aromatic nitrogen oxides (impurities 2, 4, 6, and 8) are all controlled as genotoxic impurities of API. At present, the literature on the research of potential genotoxic impurities of PER only reports the determination method of 8. Under this chromatographic condition, the determination of impurities 2 and 4 cannot be met. Therefore, a new method needs to be established to determine the four potential genotoxic impurities at the same time. Summary of the invention
[0004] The technical problem to be solved by the present invention is to provide a method for determining four potential genotoxic impurities in the raw material of perampanel.
[0005] The present invention is achieved in that:
[0006] A method for determining four potential genotoxic impurities in a perampanel raw material drug, the method adopts high performance liquid chromatography for determination, the potential genotoxic impurities are 2-(6-oxyylidene-1H-pyridin-3-yl)pyridine-1-oxide (2), 2-(6-oxyylidene-1-phenylpyridin-3-yl)pyridine-1-oxide (4), 2-(5-bromo-6-oxyylidene-1-phenylpyridin-3-yl)pyridine-1-oxide (6), 2-[5-(2-cyanophenyl)-6-oxyylidene-1-phenylpyridin-3-yl]pyridine-1-oxide (8); the specific steps are as follows:
[0007] (1) Preparation of test solution:
[0008] Weigh the perampanel test sample and dissolve it in the diluent;
[0009] (2) Preparation of reference solution:
[0010] Weigh each impurity separately, add diluent to dissolve and mix, and dilute with diluent to prepare each reference solution;
[0011] (3) Chromatographic conditions
[0012] A Welch Ultramate PFP chromatographic column 250×4.6 mm, a filler particle size of 5 μm, and a Welch Ghost-Buster ghost peak trapping column 4.0 mm×50 mm were used. Acetonitrile was used as mobile phase A, and 10 mmol of diammonium phosphate (pH adjusted to 3.0 with phosphoric acid) was used as mobile phase B. Gradient elution was performed and the detection wavelength was 250 nm.
[0013] Furthermore, in step (3), the flow rate is 1 ml.min -1 .
[0014] Furthermore, in step (3), the column temperature is 30°C.
[0015] Furthermore, in step (3), the injection volume is 10 μl.
[0016] Furthermore, in the steps (1) and (2), the diluent is acetonitrile:water=70:30 (v:v).
[0017] Furthermore, in step (2), the reference solution contains 0.625 μg of each impurity per milliliter.
[0018] Furthermore, in the step (3), the gradient elution is: 0-5 min, 95% B; 5-31 min, 95% B→20% B; 31-36 min, 20% B; 36-37 min, 20% B→95% B; 37-46 min, 95% B.
[0019] The present invention has the following advantages: the method of the present invention is simple, rapid, and highly versatile, and is suitable for the detection and quality control of four potential genotoxic impurities 2, 4, 6, and 8 in perampanel. Using the method of the present invention, the four impurities are within the range of 0.25-1.88 μg.ml -1 Within the range, the peak area and concentration had a good linear relationship, and r was greater than 0.9992; the average recoveries were 99.01%, 97.01%, 98.27% and 102.50%, respectively, and the RSD values were all less than 5%; the repeatability results were 3.46%, 2.90%, 2.57% and 3.08%, respectively; the reference solution and the sample recovery solution had good stability within 63.5 hours at room temperature. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] The present invention will be further described below in conjunction with embodiments with reference to the accompanying drawings.
[0021] Figure 1 This is the synthetic route of Perampanel.
[0022] Figure 2 Specificity test results
[0023] Figure 3 The influence of different chromatographic columns on the peak shape of impurity 4; a: Waters sunfire C18; b: Welch PFP; c: Welch Ultimate XB-C18.
[0024] Figure 4 The peaks under different buffer salt systems; a: 0.01 mol.L -1 Ammonium dihydrogen phosphate (pH 3.0); b: 0.01 mol.L -1 Potassium dihydrogen phosphate (pH 3.0). DETAILED DESCRIPTION
[0025] 1. Instruments and test drugs
[0026] 1.1. Instruments:
[0027] Dionex Ultimate 3000 high performance liquid chromatograph (Dionex, USA); XS205D 1 / 100000 balance (Mettler Toledo, Switzerland); PB-10 pH meter (Sartorius, Germany).
[0028] 1.2. Drug testing
[0029] Perampanel reference substance, purity 99.93%, batch number PM-ZY221107; impurity 2 reference substance, purity 98.13%, batch number RM1-ZZ5-QYF211108-1; impurity 4 reference substance, purity 98.61%, batch number IM2-ZZ2-QYF221124; impurity 6 reference substance, purity 99.26%, batch number IM1-ZZ5-QYF221125; impurity 8 reference substance, purity 99.73%, batch number PM-ZZ1-QYF220807; the above reference substances are all synthesized by our team. Ammonium dihydrogen phosphate is AR grade, purchased from Sinopharm Group; acetonitrile is chromatographic grade, purchased from Shanghai Xingke High Purity Solvent Effective Company; the test water is ultrapure water.
[0030] 2. Methods and Results
[0031] Solution preparation
[0032] 2.1.1 Diluent:
[0033] Acetonitrile:water=70:30 (v:v).
[0034] 2.1.2 Reference solution:
[0035] Take about 12.5 mg of each impurity, weigh accurately, place in a 10 ml volumetric bottle, add diluent to dissolve and quantitatively dilute to scale, and mix by ultrasonic. Accurately measure 50 μl of each of the above solutions in a 10 ml volumetric bottle, add diluent to quantitatively dilute to scale, and prepare an impurity reference stock solution containing 6.25 μg of each impurity per ml. Accurately measure 1 ml of the impurity reference stock solution in a 10 ml volumetric bottle, add diluent to quantitatively dilute to scale to obtain an impurity reference solution containing 0.625 μg of each impurity per ml.
[0036] 2.1.3 Test solution:
[0037] Weigh about 50 mg of the perampanel test sample, accurately weigh it, place it in a 10 ml volumetric flask, add the diluent and quantitatively dilute it to the scale, and dissolve it by ultrasonication.
[0038] Chromatographic conditions
[0039] A Welch Ultimate PFP chromatographic column (250×4.6mm, 5μm) was connected in series with a Welch Ghost-Buster ghost peak trapping column 4.0mm×50mm. The injection volume was 10μl, acetonitrile was used as mobile phase A, and 10mmol of ammonium dihydrogen phosphate (the pH was adjusted to 3.0 with phosphoric acid) was used as mobile phase B. Gradient elution was performed (0-5min, 95% B; 5-31min, 95% B→20% B; 31-36min, 20% B; 36-37min, 20% B→95% B; 37-46min, 95% B), with a flow rate of 1ml / min, a detection wavelength of 250nm, a column temperature of 30°C, and an injection volume of 10μl.
[0040] 2.3. Specificity test
[0041] Take 10 μl of blank solution (diluent), impurity reference solution and test solution respectively, and analyze according to the chromatographic conditions shown in "2.2". Record the chromatogram. Figure 2 The results showed that the elution time of each chromatographic peak was 29.197min for impurity, 417.183min for impurity, 619.343min for impurity, 821.703min for impurity, and 26.443min for perampanel. The blank solvent had no interference with the determination. Under the chromatographic conditions shown in "2.2", the established method had good specificity.
[0042] 2.4. Limit of detection and limit of quantification
[0043] Take the impurity reference stock solution, dilute it step by step, take the diluted solution for sampling and analysis, take the mass concentration corresponding to the signal-to-noise ratio (S / N) of about 3 and 10 as the detection limit and quantitative limit, the detection limit of impurity 2 is 62.5ng / ml, the detection limits of impurity 4, impurity 6, and impurity 8 are 5.32ng / ml, 5.27ng / ml, and 5.13ng / ml respectively; the quantitative limit of impurity 2 is about 250ng / ml, and the quantitative limits of impurity 4, impurity 6, and impurity 8 are 15.96ng / ml, 15.81ng / ml, and 15.39ng / ml respectively. It shows that the sensitivity of this method can meet the detection requirements.
[0044] 2.5. System precision
[0045] Take the impurity reference solution under "2.1.2", inject it six times in succession, record the chromatogram, and examine the RSD of peak area and retention time. The RSD of peak area of impurities 2, 4, 6, and 8 are calculated to be 4.89%, 0.70%, 0.47%, and 0.34% respectively. The RSD of retention time is less than 1%, indicating good injection precision.
[0046] 2.6. Linearity test
[0047] Take the impurity reference stock solution under "2.1.2" and dilute it into 20%, 40%, 50%, 100%, 150%, 200%, 300% linear series solutions of the limit concentration according to the preparation method of the reference solution. Take the above solution for injection analysis, and perform linear regression with mass concentration as the horizontal axis and peak area as the vertical axis. The linear equation and correlation coefficient are shown in Table 1. The results show that each impurity has a good linear relationship with its peak response value within its linear range.
[0048] Table 1 Linearity test results
[0049]
[0050] 2.7. Sample recovery test
[0051] Accurately weigh 50 mg of the perampanel test sample and place it in a 10 ml volumetric flask, for a total of 9 portions. Accurately measure 0.5 ml, 1 ml, and 1.5 ml of the impurity reference stock solution described in "2.1.2", add diluent to dilute to the scale, shake well, and obtain 3 portions of three test sample solutions with low (0.3125 mg / ml), medium (0.6250 mg / ml), and high (0.9375 mg / ml) concentrations. Determine according to the law, and the recovery data are shown in Table 2. The results show that the recoveries of the four impurities are between 91.99% and 106.47%; according to the provisions of 3101 of the fourth volume of the 2020 edition of the "Pharmacopoeia of the People's Republic of China", the recovery rate of impurities with a limit of 100 ppm should be between 90-108%, so this method has good accuracy.
[0052] Table 2 Recovery test results
[0053]
[0054]
[0055]
[0056] 2.8. Repeatability test
[0057] Accurately weigh 50 mg of the perampanel test sample and place it in a 10 ml volumetric flask, for a total of 6 portions. Accurately measure 1 ml of the impurity reference stock solution described in "2.1.2", add diluent to dilute to the scale, shake well, and obtain 6 portions of the test sample solution with a medium concentration of (0.6250 mg / ml). Determine according to the method, and the recoveries of impurities 2, 4, 6, and 8 are RSD (n=6) of 3.46%, 2.90%, 2.57%, and 3.08%, respectively, indicating that this method has good repeatability.
[0058] 2.9. Stability test
[0059] Take the impurity reference solution under "2.1.2" and the test solution under "2.1.3", place them at room temperature for 63.5 hours, take 5 time points separately, and measure the peak areas of the 4 impurities. The results show that the retention time RSD values of impurities 2, 4, 6, and 8 are 2.61%, 0.34%, 0.29%, and 0.31%, respectively; the peak area RSD values are 2.62%, 0.89%, 0.38%, and 0.99%, respectively. The test solution did not detect the above impurities within 63.5 hours at room temperature, indicating that the test sample is relatively stable in the solvent and will not degrade to produce the above impurities.
[0060] 2.10. Sample determination
[0061] Different batches of perampanel API were used to prepare test solution according to the method under "2.1.3", and the impurity reference solution was prepared according to the method under "2.1.2", and the results were determined by external standard method. The results are shown in Table 3. From the data, it can be seen that impurity 8 was detected in the two batches of samples, and the content of the detected impurities was within the limit, which fully verified the safety of the proposed synthesis process of the API.
[0062] Table 3 Sample measurement results
[0063]
[0064]
[0065] 3. Discussion and Conclusion
[0066] 3.1. Selection of detection method
[0067] Perampanel and four potential genotoxic impurities all contain conjugated structures. HPLC-UV detection can meet the sensitivity requirements of the four impurities at the same time, so a low-cost and easy-to-operate UV detector was selected for detection.
[0068] 3.2. Selection of chromatographic conditions
[0069] We screened three chromatographic columns: Welch Ultramate XB-C18, Welch PFP, and Waters sunfire. Figure 3 As shown in the figure, impurity 4 has a good peak shape under Welch PFP conditions; adding a trapping column can eliminate ghost peak interference.
[0070] Since the response of impurity 2 is low, the maximum absorption wavelength of impurity 2, 250nm, is selected as the detection wavelength; under this wavelength condition, 5mg / ml (the concentration of the perampanel test sample, the limit concentration of the impurity is 0.625μg / ml (125ppm)), and the injection volume of 10μl can ensure that the sensitivity of impurity 2 meets the requirements, and the peak shape of impurity 4 is good. Increasing the injection volume will deteriorate the peak shape of impurity 4.
[0071] 3.3. Choice of aqueous phase
[0072] After confirming PFP as the chromatographic column, we continued to optimize the method and compared the peaks of potassium salt and ammonium salt buffer systems on the PFP column. Figure 4 As shown, when ammonium dihydrogen phosphate is used as the buffer salt system, the baseline is more stable than that of potassium salt, and the separation degree between impurity 8 and its previous unknown impurities is better.
[0073] 3.4. Screening of diluents
[0074] Perampanel and impurity 4 have poor solubility in methanol. We initially tried to use 50% acetonitrile (water) as a diluent. It took a long time of ultrasound to completely dissolve it, and Perampanel would precipitate over time. In the sample recovery solution, the precipitation of Perampanel was accompanied by the analysis of impurity 8, resulting in a low recovery rate. Referring to the patent preparation method (CN202111344629.4) A method for detecting genotoxic impurities of Perampanel, published on January 28, 2022), first add 5 ml of acetonitrile, then add 1 ml of DMF, shake well to dissolve, and then add water to make up to volume. The solution prepared in this way will also precipitate in a short time. The final diluent selected was acetonitrile: water = 70:30 (v:v). Under this diluent system, the sample and impurity state are relatively stable.
[0075] 3.5. Conclusion
[0076] In this study, HPLC was used to determine the four potential genotoxic impurities (2, 4, 6, and 8) in the raw material of perampanel, and the established method was systematically validated. The established method has high sensitivity, good specificity, and is easy to operate, and can be used to verify the safety of the synthetic process.
[0077] Although the specific implementation modes of the present invention are described above, those skilled in the art should understand that the specific implementation modes described are only illustrative and are not intended to limit the scope of the present invention. Equivalent modifications and changes made by those skilled in the art in accordance with the spirit of the present invention should be included in the scope of protection of the claims of the present invention.
Claims
1. A method for determining four potential genotoxic impurities in perampanel API. Features: The method adopts high performance liquid chromatography for determination, and the potential genotoxic impurities are 2-(6-oxygenylidene-1H-pyridin-3-yl)pyridine-1-oxide 2, 2-(6-oxygenylidene-1-phenylpyridin-3-yl)pyridine-1-oxide 4, 2-(5-bromo-6-oxygenylidene-1-phenylpyridin-3-yl)pyridine-1-oxide 6, and 2-[5-(2-cyanophenyl)-6-oxygenylidene-1-phenylpyridin-3-yl]pyridine-1-oxide 8 respectively; the specific steps are as follows: (1) Preparation of test solution: Weigh the perampanel test sample and dissolve it in the diluent; (2) Preparation of reference solution: Weigh each impurity separately, add diluent to dissolve and mix, and dilute with diluent to prepare each reference solution; (3) Chromatographic conditions A Welch Ultimate PFP column 250×4.6 mm with a filler particle size of 5 μm was used, acetonitrile was used as mobile phase A, 10 mmol of ammonium dihydrogen phosphate with the pH adjusted to 3.0 with phosphoric acid was used as mobile phase B, gradient elution was performed, and the detection wavelength was 250 nm.
2. The method according to claim 1, Features: In step (3), the flow rate is 1 ml.min -1 .
3. The method according to claim 1, Features: In the step (3), the column temperature is 30°C.
4. The method according to claim 1, Features: In the step (3), the injection volume is 10 μl.
5. The method according to claim 1, Features: In the steps (1) and (2), the diluent is acetonitrile:water=70:30 v:v.
6. The method according to claim 1, Features: In step (2), the reference solution contains 0.625 μg of each impurity per milliliter.
7. The method according to claim 1, Features: In the step (3), the gradient elution is: 0-5 min, 95% B; 5-31 min, 95% B→20% B; 31-36 min, 20% B; 36-37 min, 20% B→95% B; 37-46 min, 95% B.
8. The method according to claim 1, Features: A Welch Ghost-Buster ghost peak trapping column 4.0 mm × 50 mm was used in series with a PFP chromatographic column.
